GUFICBIOGufic Biosciences Limited
Pharma · Drug Manufacturers - Specialty & Generic · NSE · as of 2026-07-20 (delayed ~30 min in market hours)
₹393.75
▲ 3.10%Decent
Price & Volume
Loading chart…
Key Ratios
Market Cap (₹ cr)3,948.60
P/E61.33
P/B5.95
PEG0.33
ROE %10.14
ROCE %11.30
Debt / Equity0.61
EPS6.42
Revenue Growth %22.80
Profit Growth %183.10
Dividend Yield %0.03
Promoter Holding %77.55
FII Holding %3.68
DII Holding %—
Beta-0.04
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
| Pullback to 21-EMA | LONG | 80% | ₹393.75 | ₹378.30 | ₹463.45 | 4.51 |
HOLDConviction 74%
The picture
- • Revenue growth: 22.8% YoY
- • Profit growth: 183.1% YoY
- • Debt/Equity: 0.61
- • RSI: 58
- • Price vs EMA21: above
- • Price vs SMA50: above
- • Pullback to 21-EMA signal (setup quality 80%)
Bull case
- • Revenue growth: 22.8% YoY
- • Profit growth: 183.1% YoY
- • Debt/Equity: 0.61
- • RSI: 58
Bear case
- • ROE: 10.1%
- • Valuation vs sector: P/E 61.3 vs sector 38.6
- • MACD: bearish
- • Volume: 0.1x 20-day average
Key risks
- • ROE: 10.1%
- • Valuation vs sector: P/E 61.3 vs sector 38.6
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Entry (CMP)
₹393.75
Stop Loss
₹354.52
risk 10%
Target 1 (1.5R)
₹452.60
+14.9%
Target 2 (3R)
₹511.44
+29.9%
Support (20d)
₹358.10
Resistance (52w)
₹448.00
Risk : Reward
1 : 1.5 → 1 : 3
risking ₹39.23/share
ATR (volatility)
₹16.88
avg daily range
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹16.88). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.
Score Breakdown
Fundamental
67
Technical
69
Momentum
84
Risk (safety)
55